Remicade Safety Line.

Trial Profile

Remicade Safety Line.

Phase of Trial: Phase IV

Latest Information Update: 07 Oct 2015

At a glance

  • Drugs Infliximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Merck & Co; Schering-Plough
  • Most Recent Events

    • 31 Jan 2012 Actual patient number (576) added as reported by
    • 31 Jan 2012 Status changed from active, no longer recruiting to completed as reported by
    • 12 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top